As with any treatment, when contemplating percutaneous coronary intervention (PCI) we must remain clear regarding our goals.

More than 30 years of evidence show that statin (in particular high-intensity statin) therapy reduces major vascular events in patients with atherosclerotic cardiovascular disease (ASCVD).

Measurement of the left atrial (LA) volume index is a standard when evaluating the left atrium in echocardiography.

The number of adults with elevated blood pressure (BP) has doubled over the past 3 decades, and hypertension is among the leading modifiable risk factors for attributable deaths.

Although “innovation” has become the buzzword of the decade, in health care, technological innovation over the last century has been transformative.